本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.8669
-0.0057-0.65%
盘后0.90000.0331+3.82%19:58 EDT
成交量:34.62万
成交额:30.19万
市值:4,051.89万
市盈率:-0.96
高:0.9170
开:0.8818
低:0.8511
收:0.8726
数据加载中...
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/12/14

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/09

重要事件披露

8-K - Current report
2020/11/19

企业合并公告

425 - Prospectuses and communications, business combinations
2020/11/19

重要事件披露

8-K - Current report
2020/11/13

重要事件披露

8-K - Current report